Business
Appointment of Chief Financial Officer
Appointment of Chief Financial Officer.
About this update from Venture Life Group Plc
[{"type":"text","content":"\n \nRNS Number : 6279X Venture Life Group PLC 01 May 2019 \n\n1 May 2019\nVenture Life Group plc\n(\"Venture Life\" or the \"Group\")\nAppointment of Chief Financial Officer\nVenture Life Group plc (AIM: VLG), a leader in developing, manufacturing and commercialising products for the international self-care market, today announces that it has appointed Andrew Waters, FCA, to the Board of Venture Life as Chief Financial Officer with immediate effect. \nAndrew has been working closely with the Board since February 2019 after the departure of former CFO, Adrian Crockett, earlier this year. Andrew is a Chartered Accountant having previously worked at PWC and then GlaxoSmithKline plc, where he spent 16 years in various financial and business management positions. Following this, Andrew co-founded two businesses, Cubase Consulting Ltd and Infirst Healthcare Ltd, which he led through three successful funding rounds, raising in excess of £40 million from private equity.\nDr Lynn Drummond, Chair of Venture Life, said: \"We are delighted to welcome Andrew to the Board of Venture Life. Andrew brings a range of skills to the team to support the ambitious plans we have for the business over the coming years. I am confident Andrew will be a valuable and complementary addition to the executive team.\" \n \nDisclosures required by Schedule 2(g) of the AIM Rules for Companies\nIn the past 5 years, Mark Andrew Waters, aged 52, has held the following positions where he was acting in the capacity of a Director:\n\n\n\nCurrent Directorships:\n\n\n\n\nCubase Consulting Ltd\n\n\n\n\nAW Chartered Accountant\n\n\n\n\n\n\n\n\n\nPast Directorships:\n\n\n\n\nInfirst Healthcare Ltd\n\n\n\n\nInfirst Healthcare Inc (USA)\n\n\n\n\nInfirst Healthcare Ltd (Ireland) (formerly Immunocopea Ltd)\n\n\n\n\nRespicopea Holding Ltd\n\n\n\n \nAndrew Waters does not have any interest in the ordinary shares of the Company.\nThere are no further disclosures to be made pursuant to Schedule Two, paragraph (g) of the AIM Rules for Companies.\nFor further information, please contact:\n\n\n\nVenture Life Group PLC\n\n\n+44(0) 1344 578004\n\n\n\n\nJerry Randall, Chief Executive Officer\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCenkos Securities Ltd (Nomad and Broker)\n\n\n+44(0)20 7397 8900\n\n\n\n\nMark Connelly / Stephen Keys / Cameron MacRitchie (Corporate Finan...